MORGAN STANLEY PLC/CALL/ZOETIS/175/0.1/20.12.24 | Real-time Bid/Ask 03:29:01 2024-07-17 am EDT | ||
| 1.81 EUR / 1.85 EUR | +7.65% |
|
| Current month | +6.92% | ||
| 1 month | +28.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 1.7 | +7.59% |
| 24-07-15 | 1.58 | -4.24% |
| 24-07-12 | 1.65 | +3.77% |
| 24-07-11 | 1.59 | +14.39% |
| 24-07-10 | 1.39 | -4.14% |
Delayed Quote Börse Stuttgart
Last update July 16, 2024 at 02:49 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | MB3542 |
| ISIN | DE000MB35428 |
| Date issued | 2023-02-02 |
| Strike | 175 $ |
| Maturity | 2024-12-20 (157 Days) |
| Parity | 10 : 1 |
| Emission price | 2.89 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.2 € |
|---|---|
| Lowest since issue | 0.59 € |
| Spread | 0.04 € |
| Spread % | 2.17% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
182.9
USD
Average target price
210.2
USD
Spread / Average Target
+14.89%
- Stock Market
- Warrants
- Warrant
